Cargando…
Current treatment preferences in acute myeloid leukemia: a survey in Brazil
INTRODUCTION: : Most adults with acute myeloid leukemia (AML) will eventually relapse from their disease. The combination of 7-day cytarabine and an anthracycline on days 1–3 (the so called “7 + 3” regimen) can be considered standard of care of younger patients with AML. However, the treatment of th...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417458/ https://www.ncbi.nlm.nih.gov/pubmed/31780390 http://dx.doi.org/10.1016/j.htct.2019.07.005 |